Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA: Anonymity Assured In Pending Cosmetic Manufacturing Practices Survey

Executive Summary

The agency clarified in an email to Rose Sheet that an independent contractor would be tasked with conducting a planned survey on current cosmetic manufacturing practices, which remains subject to public comment and OMB approval. Respondents could count on their responses to be anonymous, FDA says.

Advertisement

Related Content

FDA Appears To Be Prepping For Cosmetics Regulatory Changes, Ingredient Review
FDA Announces Planned Survey Of Current Cosmetics Manufacturing Practices
‘Something’s Going To Happen’: Former FDAer John Bailey On Cosmetics Reform Legislation
ICCR Ushers Forth Updated Cosmetic GMP Guidelines From FDA

Topics

Advertisement
UsernamePublicRestriction

Register

RS121704

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel